BioSpace News Archive

Fluidigm (Nasdaq:FLDM) today announced that Covance, the drug development business of LabCorp® (NYSE: LH), a leading global life sciences company, has selected Fluidigm’s CyTOF® technology and the industry-leading Maxpar® Direct™ Immune Profiling Assay™ to develop highly multiplexed immune profiling services.

Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that it will release fourth-quarter and full-year 2019 results on Wednesday, February 26th, 2020, after the market closes.

CALGARY, Alberta, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM; OTC: HMTXF) is pleased to announce the appointment of Dr. Ronnie Hershman, M.D., F.C.C.S., to its Board of Directors. Dr. Hershman is a successful, practicing cardiologist with over three decades of experience. Dr. Hershman graduated Magna Cum Laude from the Sophie Davis Center for Biomedical Research in 1980 and received his medical degree from Mount Sinai Medical Center in 1982. He

Calvin Roberts MD, Senior Vice President and Chief Medical Officer, Eye Care at Bausch Health Companies and Clinical Professor of Ophthalmology at Weill Cornell Medical College, has been elected President and CEO of Lighthouse Guild.

Epilepsy Foundation today announced the addition of Brazilian-American fashion and beauty entrepreneur Camila Coelho as an END EPILEPSY® Ambassador

Today Change Healthcare (Nasdaq: CHNG) and the HealthCare Executive Group (HCEG) published the 2020 Industry Pulse Report, an annual study that takes the pulse of healthcare executives nationwide, and reports on the challenges, issues, and opportunities they see in the coming year for healthcare.

Feb. 10, 2020 14:00 UTC SEATTLE--( BUSINESS WIRE )-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the Company will release fourth quarter and fiscal year 2019 financial results after the close of the market on Wednesday, February 26, 2020. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update. Individuals interested i

International Isotopes Inc. (OTCQB: INIS) (the “Company”) is pleased to announce it has received approval from the U.S. Food and Drug Administration (FDA) for its SODIUM IODIDE I-131 pharmaceutical product. SODIUM IODIDE I-131 is a radioactive therapeutic agent indicated for the treatment of hyperthyroidism and carcinoma of t

A new study, published in Lancet Digital Health, shows the added value of AI-aided breast cancer detection from mammography images.

The Astellas Global Health Foundation (“Foundation”) and the Academic Model Providing Access to Healthcare (AMPATH), under the direction of the Indiana University Center for Global Health, announced today that the Foundation has awarded a $1.35 million grant over three years to AMPATH to provide 400,000 people with access to mental health programming in western Kenya.